ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

Eli Lilly India (Lilly) and Lupin Limited (Lupin) announced on 29^th July, 2011 that they have entered into a strategic collaboration to promote and distribute Lilly’s Huminsulin range of products, including Huminsulin RTM, Huminsulin NPHTM, Huminsulin 50/50TM, Huminsulin 30/70TM and Humapen Ergo II. Lupin’s India formulations business will promote and distribute the range of products in India and Nepal, virtually doubling the number of sales representatives behind the diabetes care product.

Govt. of Himachal Pradesh took up initiative in early seventies to set up a CSIR lab to make prudential use of the natural resources of the region. After several levels of discussions a formal request was made by then Chief Minister of HP to Vice President, CSIR in 1982 for initiating the matter, and giving final shape to the proposal.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’.

This time people performed well. looks like approved than previous tests. Passing marks was 40 % and so many of the candidates reach there to pass. Let me remind you there was no negative marks system otherwise it can affect your result. But anyways overall it was nice performance.

”Saraswathi Institute of Medical Sciences” is a budding institute in the field of medical-education and research. It is an institution set up with the objective of providing medical services to the society with care and attention, personal touch and perfection. The institute is promoted by “Saraswathi Ammal Educational and Charitable Trust”-Chennai,under the guidance of Shri. J. Ramchandran, Chairman of the institute and chancellor of AMET university-Chennai.

Lupin Pharmaceuticals, Inc. (LPI) announced on 29^th aug, 2011 that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200 and 300 mg strengths. Lupin will begin shipping its Tramadol ER shortly.

The Public Health Foundation of India (PHFI) is a public private partnership that has collaboratively evolved through consultations with multiple constituencies including Indian and international academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health.

SAVA Medica Limited is a leading pharmaceutical company based in India.
Human life is precious to us. That is why we, at SAVA Medica, are committed to provide such products which can improve human health & life at affordable cost.
To accomplish our aim we, at SAVA Medica, are engaged in manufacturing & marketing of the branded generic medicines at affordable prices.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’.

Eligibility Criteria:
To Appear In MAH-MPH-CET 2011
For Admission to M.PHARM through GPAT Qualified Candidates:
For Admission to M.PHARM through MAH-MPH-CET 2011 Candidates:
Other Eligibility Criteria

[adsense:336x280:8701650588]

July 2011

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’.

Ecron Acunova is a CRO combining the strengths from four previously independent expert CROs on two continents serving established clinical research geographies of Europe, India and South East Asia (SEA). This integration enabled the four expert CRO’s to increase the value to sponsors with patient recruitment in India, SEA, Nordic countries, West Europe and East Europe with faster patient enrolment in clinical trials and timely database lock. It added services of early development and central lab.

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.

The Razi Advantage comes from linking the entrepreneurial energy of their doctors to a brand that patients can trust. With the Razi Clinics brand, they offer a patient-centred approach to health care with a guarantee of affordability.

Post: Pharmacits